{
  "first_published_at": "2009-12-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087717", 
  "title": "Drug alert: recall of Gaviscon Advance Peppermint Flavour, Boots Heartburn Relief Peppermint Flavour, Peptac Peppermint Liquid, and Peptac Liquid Aniseed Flavour", 
  "tags": "{\"parsed_therapeutic\": [\"cancer\", \"gi-hepatology-pancreatic-disorders\", \"immunosuppression-transplantation\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Cancer\", \"GI, hepatology and pancreatic disorders\", \"Immunosuppression and transplantation\"]}", 
  "_document_number": 222, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "cancer", 
    "gi-hepatology-pancreatic-disorders", 
    "immunosuppression-transplantation"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Drug alert: recall of Gaviscon Advance Peppermint Flavour, Boots Heartburn Relief Peppermint Flavour, Peptac Peppermint Liquid, and Peptac Liquid Aniseed Flavour</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: December 2009</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--Some batches are being recalled from the market because of low levels of microbial contamination-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>The following batches of medicine are being recalled from the market because of low levels of microbial contamination:</p><table border=\"1\" class=\"standard\" style=\"WIDTH: 775px; HEIGHT: 132px\" width=\"775\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td width=\"50%\">&nbsp;<strong>Product</strong></td>\r\n\t\t\t\t\t<td width=\"50%\">&nbsp;<strong>Batch number(s)*</strong></td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&nbsp;Gaviscon Advance Peppermint Flavour&dagger;&nbsp;</td>\r\n\t\t\t\t\t<td>&nbsp;924471 and 925071</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&nbsp;Boots Heartburn Relief Peppermint Flavour&Dagger;</td>\r\n\t\t\t\t\t<td>&nbsp;41808</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&nbsp;Peptac Peppermint Liquid&Dagger;</td>\r\n\t\t\t\t\t<td>&nbsp;41808 and 41957</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&nbsp;Peptac Liquid Aniseed Flavour&Dagger;</td>\r\n\t\t\t\t\t<td>&nbsp;41757</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><p><strong>*</strong>All are 500 mL bottles. &dagger;A low proportion of bottles in batch 924471 are known to be affected and batch 925071 is being recalled as a precautionary measure (although no bottles in this batch are reported defective). &Dagger;Precautionary recall due to low-level microbial contamination detected in a small number of samples from these batches.</p><p>The causes of the contaminations are under investigation and are unlikely to be harmful to normally healthy consumers. However, if these products are being used by patients with suppressed immune systems (eg, those receiving chemotherapy), the risk of infection and other adverse reactions cannot be ruled out. GPs or pharmacists receiving enquiries from such patients are requested to give professional advice and refer to the responsible treatment centre where necessary.</p><p>Further information is available in drug alerts issued <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062825\" target=\"_blank\">Nov 17</a> and <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062892\" target=\"_blank\">Nov 18</a>, 2009.</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update Dec 2009, vol 3 issue 5: 8a.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>The following batches of medicine are being recalled from the market because of low levels of microbial contamination:</p><table border=\"1\" class=\"standard\" style=\"WIDTH: 775px; HEIGHT: 132px\" width=\"775\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td width=\"50%\">&#160;<strong>Product</strong></td>\r\n\t\t\t\t\t<td width=\"50%\">&#160;<strong>Batch number(s)*</strong></td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&#160;Gaviscon Advance Peppermint Flavour&#8224;&#160;</td>\r\n\t\t\t\t\t<td>&#160;924471 and 925071</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&#160;Boots Heartburn Relief Peppermint Flavour&#8225;</td>\r\n\t\t\t\t\t<td>&#160;41808</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&#160;Peptac Peppermint Liquid&#8225;</td>\r\n\t\t\t\t\t<td>&#160;41808 and 41957</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>&#160;Peptac Liquid Aniseed Flavour&#8225;</td>\r\n\t\t\t\t\t<td>&#160;41757</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><p><strong>*</strong>All are 500 mL bottles. &#8224;A low proportion of bottles in batch 924471 are known to be affected and batch 925071 is being recalled as a precautionary measure (although no bottles in this batch are reported defective). &#8225;Precautionary recall due to low-level microbial contamination detected in a small number of samples from these batches.</p><p>The causes of the contaminations are under investigation and are unlikely to be harmful to normally healthy consumers. However, if these products are being used by patients with suppressed immune systems (eg, those receiving chemotherapy), the risk of infection and other adverse reactions cannot be ruled out. GPs or pharmacists receiving enquiries from such patients are requested to give professional advice and refer to the responsible treatment centre where necessary.</p><p>Further information is available in drug alerts issued <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062825\" target=\"_blank\">Nov 17</a> and <a href=\"http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062892\" target=\"_blank\">Nov 18</a>, 2009.</p><p>&#160;</p><p><em>Article citation: Drug Safety Update Dec 2009, vol 3 issue 5: 8a.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2009-12-01", 
  "date_last_modified": "2010-08-27", 
  "_assets": [], 
  "_item_id": 222, 
  "summary": "", 
  "body": "Article date: December 2009\n\nThe following batches of medicine are being recalled from the market because of low levels of microbial contamination:  \n  \n Product |   |  Batch number(s)* |   \n Gaviscon Advance Peppermint Flavour†  |   |  924471 and 925071 |   \n Boots Heartburn Relief Peppermint Flavour‡ |   |  41808 |   \n Peptac Peppermint Liquid‡ |   |  41808 and 41957 |   \n Peptac Liquid Aniseed Flavour‡ |   |  41757 | \n\n*All are 500 mL bottles. †A low proportion of bottles in batch 924471 are known to be affected and batch 925071 is being recalled as a precautionary measure (although no bottles in this batch are reported defective). ‡Precautionary recall due to low-level microbial contamination detected in a small number of samples from these batches.\n\nThe causes of the contaminations are under investigation and are unlikely to be harmful to normally healthy consumers. However, if these products are being used by patients with suppressed immune systems (eg, those receiving chemotherapy), the risk of infection and other adverse reactions cannot be ruled out. GPs or pharmacists receiving enquiries from such patients are requested to give professional advice and refer to the responsible treatment centre where necessary.\n\nFurther information is available in drug alerts issued [Nov 17](http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062825) and [Nov 18](http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON062892), 2009.\n\n \n\nArticle citation: Drug Safety Update Dec 2009, vol 3 issue 5: 8a.\n"
}